Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Effect of alirocumab on incidence of atrial fibrillation after acute coronary syndromes: insights from ODYSSEY OUTCOMES Lopes, R., Steg, P. G., Bhatt, D. L., Bittner, V. A., Dauchy, A., Diaz, R., Goodman, S. G., Harrington, R. A., Jukema, J. W., Pordy, R., Sourdille, T., Szarek, M., White, H. D., Zeiher, A. M., Schwartz, G. G., ODYSSEY OUTCOMES Investigators OXFORD UNIV PRESS. 2020: 500
View details for Web of Science ID 000606106300501